NASDAQ · Drug Manufacturers - General

AMGN (AMGN) Stock

$435.89 +1.40% NASDAQ: AMGN Healthcare

Valuation

MetricValue
Price$435.89
Market Cap$235.25B
P/E Ratio27.15
P/B Ratio20.34
P/S Ratio6.23
EPS (TTM)$14.23
52-Week High$447.03
52-Week Low$269.77
Dividend Yield2.29%

Financials & Margins

MetricValue
ROE89.32%
ROA9.14%
ROCE18.03%
Gross Margin71.46%
Operating Margin31.63%
Net Margin22.93%
Debt/Equity4.90
Current Ratio1.14

Annual Financials (USD)

Metric20212022202320242025
Revenue$26.0B$26.3B$28.2B$33.4B$36.7B
Operating Profit$7.6B$9.6B$7.9B$7.3B$10.7B
Net Profit$5.9B$6.6B$6.7B$4.1B$7.7B
EPS$10.28$12.11$12.49$7.56$14.23
Op Margin29.4%36.3%28.0%21.7%29.1%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$61.2B$65.1B$97.2B$91.8B$90.6B
Total Liabilities$54.5B$61.5B$90.9B$86.0B$81.9B
Cash$8.0B$7.6B$10.9B$12.0B$9.1B
Borrowings$33.3B$38.9B$64.6B$60.1B$54.6B

Latest News

Truist Raises its Price Target on Amgen (AMGN) Insider Monkey · Jul 9, 2026 Two Drugmakers Own 90% of the Obesity Boom. One Fund Owns Both for 0.59% 24/7 Wall St. · Jul 9, 2026 Jim Cramer Says Biotech is The Hottest Group in The Market Right Now 24/7 Wall St. · Jul 9, 2026 Make Your AMGN Shares Pay You 8.7% While You Hold Them Trefis · Jul 9, 2026 Amgen (AMGN): Buy, Sell, or Hold Post Q1 Earnings? StockStory · Jul 9, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$9.3B$9.7B$8.5B$11.5B$10.0B
Investing Cash Flow$-147.0M$-7.0B$-27.3B$-2.1B$-3.8B
Financing Cash Flow$-5.1B$-6.5B$-72.0M$-324.0M$-52.0M
Net Cash Flow$1.7B$-360.0M$3.3B$1.0B$-2.8B
Free Cash Flow$8.4B$8.8B$7.4B$10.4B$8.1B

Valuation & Return Ratios

MetricValue
PEG Ratio0.86
EV / EBITDA17.02
FCF Yield4.28%
Quick Ratio1.13
Interest Coverage4.74
Return 1Y55.60%
Return 3Y82.21%
Return 5Y80.73%

Ownership

Insiders Held0.22%
Institutions Held85.07%
Institutions Float Held85.26%
Institutional HolderSharesReport Date
Blackrock Inc.47,100,4722026-03-31
Vanguard Capital Management LLC35,014,2322026-03-31
State Street Corporation30,548,4882026-03-31
Capital World Investors29,288,3432026-03-31
Morgan Stanley15,836,0582026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BMY $66.86 +0.07% 14.88 $136.58B 3.73%
BSX $47.97 -0.69% 19.42 $71.29B 0.00%
DHR $207.17 -2.99% 38.12 $145.64B 0.74%
GILD $148.94 +1.78% -56.96 $184.92B 2.21%
GSKGSK plc $51.58 9.28 $103.73B 3.49%

About AMGN

AMGN is led by CEO Robert A. Bradway, employs 28,000 people, headquartered in Thousand Oaks, US, publicly traded since 1983.

AMGN stock trades at $435.89 with a market capitalization of $235.25B. The stock is valued at a price-to-earnings (P/E) ratio of 27.15, price-to-book of 20.34, price-to-sales of 6.23. Over the past 52 weeks the stock has ranged between $269.77 and $447.03, and currently trades 2.5% below its 52-week high. It pays a dividend yielding 2.29%.

On profitability, AMGN generates a return on equity (ROE) of 89.32% — well above the market average, a sign of a high-quality business, return on capital employed of 18.03%, an operating margin of 31.63%, a net profit margin of 22.93%.

In its most recent fiscal year, AMGN reported annual revenue of $36.7B, net profit of $7.7B, revenue has compounded at 7.6% a year over the last five years, profit at 1.2% a year.

The balance sheet shows a debt-to-equity ratio of 4.90 — a leveraged balance sheet worth monitoring, a current ratio of 1.14, total assets of $90.6B, $9.1B in cash and equivalents.

AMGN has an average daily trading volume of 2,673,052 shares, a beta of 0.41 (less volatile than the overall market).

Related Healthcare Stocks

LLY Drug Manufacturers - General $1161.39 +0.40% JNJ Drug Manufacturers - General $270.47 +1.74% ABBV Drug Manufacturers - General $260.17 +1.46% MRK Drug Manufacturers - General $149.59 +1.24% UNH Medical - Healthcare Plans $396.10 +1.72% NVS Drug Manufacturers - General $161.48 +6.19% AZN Drug Manufacturers - General $161.96 -0.10% TMO Medical - Diagnostics & Research $601.51 -2.53% NVO Biotechnology $45.17 -0.35% ABT Medical - Devices $109.49 -0.79% GILD Drug Manufacturers - General $148.94 +1.78% PFE Drug Manufacturers - General $28.49 +0.09%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides